Simplex Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-576
Closed -$10K 8969
2020
Q2
$10K Sell
576
-91,258
-99% -$1.27M ﹤0.01% 6687
2020
Q1
$654K Buy
91,834
+37,198
+68% +$464K ﹤0.01% 2316
2019
Q4
$1.3M Buy
54,636
+27,228
+99% +$751K ﹤0.01% 1844
2019
Q3
$735K Buy
27,408
+8,799
+47% +$247K ﹤0.01% 2249
2019
Q2
$504K Sell
18,609
-1,101
-6% -$34.5K ﹤0.01% 2556
2019
Q1
$683K Buy
+19,710
New +$569K ﹤0.01% 2331
2018
Q4
Sell
-17,577
Closed -$361K 8237
2018
Q3
$468K Buy
17,577
+1,215
+7% +$39.7K ﹤0.01% 2703
2018
Q2
$617K Buy
+16,362
New +$626K ﹤0.01% 2245
2018
Q1
Sell
-23,671
Closed -$1.04M 7246
2017
Q4
$1.15M Buy
23,671
+10,985
+87% +$556K 0.05% 345
2017
Q3
$685K Buy
12,686
+3,387
+36% +$199K 0.03% 515
2017
Q2
$522K Sell
9,299
-4,356
-32% -$174K 0.02% 628
2017
Q1
$535K Buy
13,655
+6,390
+88% +$204K 0.02% 640
2016
Q4
$163K Sell
7,265
-2,051
-22% -$40.1K 0.01% 1192
2016
Q3
$211K Buy
9,316
+6,190
+198% +$145K 0.01% 1003
2016
Q2
$73K Sell
3,126
-13,951
-82% -$344K ﹤0.01% 1725
2016
Q1
$348K Buy
17,077
+9,979
+141% +$317K 0.03% 586
2015
Q4
$365K Buy
+7,098
New +$344K 0.03% 563
2015
Q3
Sell
-5,129
Closed -$247K 6490
2015
Q2
$233K Sell
5,129
-209
-4% -$8.41K 0.02% 726
2015
Q1
$202K Buy
5,338
+4,765
+832% +$164K 0.02% 721
2014
Q4
$16K Buy
+573
New +$15.9K ﹤0.01% 2240

Simplex Trading's PTLA Position: Q3 2020 in Review

Simplex Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 576 shares — an estimated $10K sold.

Simplex Trading first reported a position in PTLA in Q4 2014 and held it in 20 quarters. The position peaked at $1.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Simplex Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Simplex Trading sold 576 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
  • Simplex Trading first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
  • Simplex Trading's Portola Pharmaceuticals, Inc. position peaked at $1.3M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.